Toronto, Ontario–(Newsfile Corp. – March 13, 2025) – Neural Therapeutics Inc. (“Neural” or the “Company“), an ethnobotanical drug discovery company dedicated to developing therapeutic drugs for mental illnesses related to substance use disorders, is pleased to announce that it has completed the final tranche of its previously announced private placement (“Series A Financing“) and has […]